KIF13B C.3163G>A VARIANT IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: ASSOCIATIONS WITH RISK AND CLINICAL OUTCOMES

IF 1.5 Q3 HEMATOLOGY
Hematology, Transfusion and Cell Therapy Pub Date : 2026-03-01 Epub Date: 2026-03-05 DOI:10.1016/j.htct.2026.106293
Ericka Francislaine Dias Costa, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima
{"title":"KIF13B C.3163G>A VARIANT IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: ASSOCIATIONS WITH RISK AND CLINICAL OUTCOMES","authors":"Ericka Francislaine Dias Costa,&nbsp;Gustavo Jacob Lourenço,&nbsp;Carmen Silvia Passos Lima","doi":"10.1016/j.htct.2026.106293","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Oropharyngeal squamous cell carcinoma (OPSCC) is a highly malignant tumor of the head and neck region, frequently diagnosed at advanced stages and associated with unfavorable clinical outcomes. Established risk factors include tobacco use, alcohol consumption, and infection with high-risk human papillomavirus (HPV) types. It is already well known that inherited genetic variations, such as single nucleotide variants (SNVs), can influence OPSCC susceptibility and tumor behavior. The KIF13B gene encodes a kinesin-3 family motor protein that mediates microtubule-dependent transport of intracellular cargoes, processes that can affect cell signaling, proliferation, and migration. Variants located in regulatory regions, such as the 3’-untranslated region (3’-UTR), may alter gene expression by affecting microRNA binding or transcript stability. A preliminary study from our group identified an association between the KIF13B c.*3163G&gt;A SNV and tongue base cancer risk; however, its role in OPSCC and patient prognosis remains unclear.</div></div><div><h3>Objective</h3><div>To evaluate the association between KIF13B c.*3163G&gt;A genotypes and OPSCC risk, clinicopathological characteristics, and patient survival, as well as investigate its functional role in the encoded protein.</div></div><div><h3>Methods</h3><div>A total of 250 OPSCC patients and 250 controls were included in this study. Genomic DNA was extracted from peripheral blood leukocytes, and KIF13B c.*3163G&gt;A SNV genotypes were determined using polymerase chain reaction (PCR). The patients were treated with cisplatin chemoradiation with or without surgical resection of the tumor. Overall survival (OS) and event-free survival (EFS) were estimated using Kaplan-Meier analysis. The functional interaction between let-7e-3p and the KIF13B 3′-UTR harboring either allele was evaluated by luciferase reporter assays in FaDu and Detroit 562 pharyngeal carcinoma cell lines. Statistical significance was set at p = 0.05.</div></div><div><h3>Results</h3><div>The KIF13B c.*3163GG genotype was observed more frequently in OPSCC patients compared with controls (42% vs. 32%; p = 0.03), corresponding to a 1.73-fold increased risk of developing OPSCC. This genotype was also more prevalent among patients with larger tumor extension (46% vs. 28%; p = 0.01) and was associated with a 2.47-fold higher likelihood of aggressive disease (p = 0.004). At 60 months of follow-up, patients carrying the GG or GA genotypes had lower OS compared with those with the AA genotype (41.5 vs. 68.2 %, p = 0.046). No differences were observed in EFS among patients with the distinct genotypes. Functional assays demonstrated that let-7e-3p interacted more efficiently with the 3’-UTR containing the ancestral G allele than with the variant A allele in both FaDu (34.1% vs. 43.3%; p = 0.004) and Detroit 562 (37.9% vs. 61.8%; p = 0.04) pharyngeal carcinoma cell lines.</div></div><div><h3>Conclusions</h3><div>The KIF13B c.*3163G&gt;A SNV is associated with increased inherited susceptibility to OPSCC, more aggressive tumor features, and reduced OS. Functional evidence suggests that allele-specific regulation by let-7e-3p may contribute to these associations by modulating post-transcriptional control of KIF13B. Together, these findings suggest that this SNV may be relevant for OPSCC risk stratification and prognosis. Further functional studies are being conducted to better understand the biological mechanisms involved.</div></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":"48 ","pages":"Article 106293"},"PeriodicalIF":1.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137926000404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Oropharyngeal squamous cell carcinoma (OPSCC) is a highly malignant tumor of the head and neck region, frequently diagnosed at advanced stages and associated with unfavorable clinical outcomes. Established risk factors include tobacco use, alcohol consumption, and infection with high-risk human papillomavirus (HPV) types. It is already well known that inherited genetic variations, such as single nucleotide variants (SNVs), can influence OPSCC susceptibility and tumor behavior. The KIF13B gene encodes a kinesin-3 family motor protein that mediates microtubule-dependent transport of intracellular cargoes, processes that can affect cell signaling, proliferation, and migration. Variants located in regulatory regions, such as the 3’-untranslated region (3’-UTR), may alter gene expression by affecting microRNA binding or transcript stability. A preliminary study from our group identified an association between the KIF13B c.*3163G>A SNV and tongue base cancer risk; however, its role in OPSCC and patient prognosis remains unclear.

Objective

To evaluate the association between KIF13B c.*3163G>A genotypes and OPSCC risk, clinicopathological characteristics, and patient survival, as well as investigate its functional role in the encoded protein.

Methods

A total of 250 OPSCC patients and 250 controls were included in this study. Genomic DNA was extracted from peripheral blood leukocytes, and KIF13B c.*3163G>A SNV genotypes were determined using polymerase chain reaction (PCR). The patients were treated with cisplatin chemoradiation with or without surgical resection of the tumor. Overall survival (OS) and event-free survival (EFS) were estimated using Kaplan-Meier analysis. The functional interaction between let-7e-3p and the KIF13B 3′-UTR harboring either allele was evaluated by luciferase reporter assays in FaDu and Detroit 562 pharyngeal carcinoma cell lines. Statistical significance was set at p = 0.05.

Results

The KIF13B c.*3163GG genotype was observed more frequently in OPSCC patients compared with controls (42% vs. 32%; p = 0.03), corresponding to a 1.73-fold increased risk of developing OPSCC. This genotype was also more prevalent among patients with larger tumor extension (46% vs. 28%; p = 0.01) and was associated with a 2.47-fold higher likelihood of aggressive disease (p = 0.004). At 60 months of follow-up, patients carrying the GG or GA genotypes had lower OS compared with those with the AA genotype (41.5 vs. 68.2 %, p = 0.046). No differences were observed in EFS among patients with the distinct genotypes. Functional assays demonstrated that let-7e-3p interacted more efficiently with the 3’-UTR containing the ancestral G allele than with the variant A allele in both FaDu (34.1% vs. 43.3%; p = 0.004) and Detroit 562 (37.9% vs. 61.8%; p = 0.04) pharyngeal carcinoma cell lines.

Conclusions

The KIF13B c.*3163G>A SNV is associated with increased inherited susceptibility to OPSCC, more aggressive tumor features, and reduced OS. Functional evidence suggests that allele-specific regulation by let-7e-3p may contribute to these associations by modulating post-transcriptional control of KIF13B. Together, these findings suggest that this SNV may be relevant for OPSCC risk stratification and prognosis. Further functional studies are being conducted to better understand the biological mechanisms involved.
Kif13b c.3163g >在口咽鳞状细胞癌中的一种变异:与风险和临床结果的关联
口咽鳞状细胞癌(OPSCC)是头颈部的一种高度恶性肿瘤,常在晚期被诊断出来,并伴有不良的临床结果。已确定的危险因素包括吸烟、饮酒和感染高危型人乳头瘤病毒(HPV)。众所周知,遗传变异,如单核苷酸变异(snv),可以影响OPSCC的易感性和肿瘤行为。KIF13B基因编码一种激酶3家族运动蛋白,介导细胞内货物的微管依赖性运输,影响细胞信号传导、增殖和迁移的过程。位于调控区域的变异,如3 ' -非翻译区(3 ' -UTR),可能通过影响microRNA结合或转录物稳定性来改变基因表达。我们小组的一项初步研究确定了KIF13B c.*3163G>;A SNV与舌基癌风险之间的关联;然而,其在OPSCC和患者预后中的作用尚不清楚。目的探讨KIF13B c.*3163G>;A基因型与OPSCC发病风险、临床病理特征及患者生存的关系,并探讨其在编码蛋白中的功能作用。方法选取OPSCC患者250例,对照组250例。提取外周血白细胞基因组DNA,采用聚合酶链反应(PCR)检测KIF13B c.*3163G>;A SNV基因型。患者接受顺铂放化疗,同时或不进行手术切除肿瘤。使用Kaplan-Meier分析估计总生存期(OS)和无事件生存期(EFS)。在FaDu和Detroit 562咽喉癌细胞系中,利用荧光素酶报告基因检测方法评估let-7e-3p与KIF13B 3 ' -UTR之间的功能相互作用。p = 0.05有统计学意义。结果与对照组相比,KIF13B c.*3163GG基因型在OPSCC患者中出现的频率更高(42% vs. 32%; p = 0.03),发生OPSCC的风险增加1.73倍。该基因型在肿瘤扩展较大的患者中也更为普遍(46% vs. 28%; p = 0.01),并且与侵袭性疾病的可能性高2.47倍相关(p = 0.004)。在60个月的随访中,携带GG或GA基因型的患者的OS低于携带AA基因型的患者(41.5% vs. 68.2%, p = 0.046)。不同基因型患者的EFS无差异。功能分析表明,let-7e-3p在FaDu(34.1%比43.3%;p = 0.004)和Detroit 562(37.9%比61.8%;p = 0.04)咽喉癌细胞系中与含有祖先G等位基因的3 ' -UTR的相互作用比与变异A等位基因的相互作用更有效。结论KIF13B c.*3163G>;A SNV与OPSCC遗传易感性增加、肿瘤特征更具侵袭性、OS降低相关。功能证据表明,let-7e-3p的等位基因特异性调控可能通过调节KIF13B的转录后控制来促进这些关联。总之,这些发现表明该SNV可能与OPSCC的风险分层和预后有关。正在进行进一步的功能研究,以更好地了解所涉及的生物学机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书